Who We Are.
Pulmonescence Diagnostics, Inc. was founded by experienced entrepreneurs on TB diagnostics with the mission to create an inexpensive, simple, sputum-based point-of-care (POC) for Drug Susceptibility Testing.
We are the NIH STTR/SBIR award recipient to continue our R&D efforts to further our knowledge and optimize our technology for commercial purposes.
Our Founders have over six decades of academic technology translation experience in the healthcare domain. Our goal is to build an experienced team to address product development and manufacturing plan, global regulatory and reimbursement path, IP protection, and fund-raising strategy.
Improving TB Diagnostics.
If you want to know more about our work and technology, please contact us at firstname.lastname@example.org.